Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Ltd. ( (AU:CHM) ) just unveiled an announcement.
Chimeric Therapeutics Ltd. announced the quotation of 5,435,254 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of August 7, 2025. This move is part of previously announced transactions and is expected to enhance the company’s capital structure, potentially impacting its market positioning and stakeholder interests.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Ltd. operates in the biotechnology industry, focusing on developing innovative therapies. The company is primarily engaged in the research and development of chimeric antigen receptor T cell (CAR-T) therapies, targeting various forms of cancer.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.75M
Find detailed analytics on CHM stock on TipRanks’ Stock Analysis page.